文献速递类风湿关节炎脊柱关节炎痛风与晶体性关节病

爱尔兰风湿病患者COVID-19结局的时间趋势:来自COVID-19全球风湿病联盟登记处的数据

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

基于COVID-19全球风湿病联盟(C19-GRA)爱尔兰提供者登记处2020年3月24日至2021年7月9日录入的212例风湿病患者数据,采用卡方检验或Fisher精确检验分析人口学与临床变量与住院和死亡的关系,并以时间段为分类变量进行逻辑回归分析时间趋势。结果显示92例(43%)住院、22例(10.4%)死亡,住院或死亡的优势比随时间均无变化。

要点

  • 212例中43%住院、10.4%死亡,住院或死亡的优势比随时间均无变化
  • 住院者中年龄增长、痛风诊断、曾吸烟、糖皮质激素使用、合并症及癌症、心血管和肺部疾病更常见
  • 死亡者中年龄增长、痛风诊断、曾吸烟、合并症及肥胖、心血管和肺部疾病更常见

核心结论

  • 爱尔兰风湿病患者的COVID-19相关住院或死亡结局均未观察到时间趋势。

研究设计与样本

  • 分析2020年3月24日至2021年7月9日录入C19-GRA提供者登记处的爱尔兰数据,共纳入212例。

主要发现

  • 212例中女性占59.4%,中位年龄58.0岁(范围13-96)。
  • 212例中92例(43%)住院,22例(10.4%)死亡。
  • 住院者中年龄增长、痛风诊断、曾吸烟、糖皮质激素使用、合并症及癌症、心血管和肺部疾病更常见。
  • 住院者中炎症性关节炎诊断、csDMARD和/或b/tsDMARD使用较少见。
  • 死亡者中年龄增长、痛风诊断、曾吸烟、合并症及肥胖、心血管和肺部疾病更常见。

关键数值与推荐

  • 采用卡方检验或Fisher精确检验(视情况而定)分析人口学和临床变量与住院及死亡可能性的差异。
  • 采用逻辑回归,以时间段为分类变量分析住院和死亡优势比的时间趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for people with rheumatic disease in Ireland. METHODS: Data entered into the C19-GRA provider registry from Ireland between 24 March 2020 and 9 July 2021 were analysed. Differences in the likelihood of hospitalization and mortality according to demographic and clinical variables were investigated using Chi-squared test or Fisher's exact test, as appropriate. Trends in odds of hospitalization and mortality over time were investigated using logistic regression with the time period as a categorical variable. RESULTS: Of 212 cases included, 59.4% were female and median age was 58.0 years (range 13-96). Of the 212 cases, 92 (43%) were hospitalized and 22 (10.4%) died. Increasing age, a diagnosis of gout, ever smoking, glucocorticoid use, having comorbidities and specific comorbidities of cancer, cardiovascular and pulmonary disease were more common in those hospitalized. A diagnosis of inflammatory arthritis, csDMARD and/or b/tsDMARD use were less frequent in those hospitalized. Increasing age, a diagnosis of gout, ever smoking, having comorbidities and specific comorbidities of obesity, cardiovascular and pulmonary disease were more common in those who died. Odds of hospitalization or mortality did not change over time. CONCLUSION: No temporal trend was observed in either COVID-19-related hospitalization or mortality outcomes for people with rheumatic disease in Ireland.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Conway R, Nikiphorou E, Demetriou CA, et al. Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry. Rheumatology (Oxford). 2022. PMID: 35258593. doi:10.1093/rheumatology/keac142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。